Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally....
The Uncategorized Assets: From Social Media to Robotics
Terumo publishes transcript of FY2027 Q1 financial results briefing Q&A session
Terumo raises FY2026 operating profit forecast to JPY 257.5 billion
Terumo sets stock option subscription price at JPY 17,280 per warrant for executives, fellows
Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States
CytoSorbents posts investor presentation outlining blood purification products, DrugSorb-ATR regulatory path